减少质子抑制剂的过度使用,以咨询,基于风险,背景意识的电子警报系统:一个受控的中断时间序列分析
Dan Luo1, Xiaolan Ye1, Hongying Zhao1
1Clinical Pharmacy Center, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310041, China.
International journal of medical informatics
|May 13, 2025
概括
一个新的电子警报系统显著减少了手术患者过度使用质子抑制剂 (PPI),提高了处方质量. 系统 系统 系统
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗信息学 医疗信息学
- 临床药房 临床药房
背景情况:
- 质子抑制剂 (PPI) 经常被过度处方,与指导方针相反.
- 电子警报系统在改善处方方面表现出不同的成功.
- 这项研究引入了一种新的系统,利用实时数据来制外科手术期间的PPI过度使用.
研究的目的:
- 评估一个新的电子警报系统,以减少外科手术期间的PPI过度使用.
- 评估系统对PPI的影响,规定质量和消费指标.
主要方法:
- 追溯控制中断时间序列分析 (2015年2月至2021年10月).
- 干预:用于IV PPI的新型电子警报系统集成到CPOE中.
- 结果:确定每日剂量 (DDD),治疗日 (DOT),处方率,高剂量订单.
主要成果:
- 在干预组中,每位患者的DDD和DOT显著下降.
- 在PPI处方率和高剂量处方的实质性减少.
- 持续消费指标警告后停用;质量指标部分反弹.
结论:
- 基于风险的咨询电子警报系统有效地减少了 PPI 的过度使用,并提高了处方质量.
- 对消费指标的持久影响表明可持续的行为变化.
- 咨询性,上下文意识的警报为优化药物使用提供了一个可扩展的解决方案.
相关概念视频
Pharmacovigilance
753
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
753
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
308
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
308
Desensitization and Tachyphylaxis
1.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.4K
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
372
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
372
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
329
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
329


